Cumberland Pharmaceuticals Inc.
CPIX
Positions held
Your positionsCPIX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $104.58M | Enterprise value | $105.10M | Trailing P/E | — | Forward P/E | 49.86 |
| PEG | 1.67 | Price / book | 6.00 | Beta | 0.04 | Dividend yield | 0.00% |
| Revenue growth | -56.3% | Earnings growth | — | Gross margin | 85.0% | Operating margin | -19.0% |
| Profit margin | -24.6% | ROE | -14.4% | ROA | -2.9% | Debt / equity | 0.28 |
| Current ratio | 0.96 | Free cash flow | -$191,169 | Analyst recommendation | none | Mean target | — |
| 52w high | $9.28 | 52w low | $1.85 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.2M | $9.1M | $13.7M | $8.3M | $0.4M | — |
| Op margin | -1898.7% | -34.3% | -10.0% | -23.7% | -819.2% | — |
| Net income | -$4.3M | -$3.3M | -$1.4M | -$1.9M | -$0.7M | — |
| Gross margin | — | 78.8% | 83.6% | 88.1% | 2317.8% | — |
| Gross profit | — | $7.2M | $11.4M | $7.3M | $8.8M | $10.3M |
| Operating income | -$3.2M | -$3.1M | -$1.4M | -$2.0M | -$3.1M | — |
- Revenue -98% vs prior quarter ($0.2M vs $9.1M).
- Gross margin 78.8% (was 83.6% prior quarter).
- Operating margin compressed to -1898.7%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $44.5M | $37.9M | $39.6M | $42.0M | — |
| Op margin | -6.3% | -17.0% | -24.2% | -13.6% | — |
| Net income | -$2.8M | -$6.5M | -$6.3M | -$5.6M | — |
| Gross margin | 85.0% | 82.6% | 84.7% | 78.3% | — |
| Gross profit | $37.9M | $31.3M | $33.5M | $32.9M | — |
| Operating income | -$2.8M | -$6.4M | -$9.6M | -$5.7M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-05 · Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ...
2026-08-04 · Cumberland Pharmaceuticals Q2 Earnings Call Highlights
2026-08-04 · Cumberland: Q2 Earnings Snapshot
2026-08-04 · CUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
2026-07-31 · Possible Generic Drug Tariffs and 2 Microcaps
2026-07-28 · CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
2026-07-15 · ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now?
2026-07-13 · Cumberland Declares Special Dividend, Approves $5 Million Share Buyback
2026-07-13 · /C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./
Price (daily)
Full chart · RSI · MACD · patterns